Skip to main content Skip to main navigation menu Skip to site footer

Fatality in a pregnant woman with COVID-19 after a cesarean section: A case report

  • Edy Parwanto ,
  • Reza Aditya Digambiro ,
  • Erdiyan Astato ,
  • Assangga Guyansyah ,


Background: SARS-CoV-2 can infect anyone, including pregnant women. Pregnant women with COVID-19 experienced fetal hypoxia and reduced amniotic fluid; therefore, a cesarean section was performed. This study aimed to report a case of fatality in pregnant women's G3P1A1 status with COVID-19 after a cesarean section.

Case Report: The patient was a 33-year-old female 36-37 weeks pregnant with G3P1A1 status and infected with SARS-CoV-2. A cesarean section is performed to save the mother and fetus in cases of pregnancy complications. Due to fetal hypoxia and reduced amniotic fluid, a cesarean section was performed, thereby changing the patient status from G3P1A1 to P2A1. The baby survived, healthy and normal after the cesarean section, while the mother underwent COVID-19 treatment. However, the patient still experienced shortness of breath and acute respiratory distress syndrome. Unfortunately, she experienced more symptoms, including hematuria, respiratory failure, acute respiratory distress syndrome, and cardiac arrest on cardiopulmonary resuscitation, before her eventual death.

Conclusion: The pregnant mother G3P1A1, successfully underwent a cesarean section, and the baby is healthy and normal. The pregnant woman's condition worsened during treatment for COVID-19, and she died.


  1. Gupta P, Kumar S, Sharma SS. SARS-CoV-2 prevalence and maternal-perinatal outcomes among pregnant women admitted for delivery: Experience from COVID-19-dedicated maternity hospital in Jammu, Jammu and Kashmir (India). J Med Virol. 2021/05/24. 2021;93(9):5505–14. Available from:
  2. Cao D, Yin H, Chen J, Tang F, Peng M, Li R, et al. Clinical analysis of ten pregnant women with COVID-19 in Wuhan, China: A retrospective study. Int J Infect Dis. 2020/04/23. 2020;95:294–300. Available from:
  3. Qiancheng X, Jian S, Lingling P, Lei H, Xiaogan J, Weihua L, et al. Coronavirus disease 2019 in pregnancy. Int J Infect Dis. 2020/04/27. 2020;95:376–83. Available from:
  4. Mylonas I, Friese K. Indications for and Risks of Elective Cesarean Section. Dtsch Arztebl Int. 2015;112(29–30):489–95. Available from:
  5. Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020/03/25. 2020;2(2):100107. Available from:
  6. Ferrazzi EM, Frigerio L, Cetin I, Vergani P, Spinillo A, Prefumo F, et al. COVID-19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome. Int J Gynaecol Obstet. 2020;149(3):377–8. Available from:
  7. Azadi J, Menias C, Ko J, Klein J, Meltzer C, Mossa-Basha M. Example reports of typical, indeterminate, atypical, and negative category CTs, with some selected correlative image examples. COVID-19 task force, RSNA COVID task force. 2020. 2020.
  8. de Jaegere TMH, Krdzalic J, Fasen BACM, Kwee RM, group C-19 CTIS-EN (CISEN) study. Radiological Society of North America Chest CT Classification System for Reporting COVID-19 Pneumonia: Interobserver Variability and Correlation with Reverse-Transcription Polymerase Chain Reaction. Radiol Cardiothorac imaging. 2020;2(3):e200213–e200213. Available from:
  9. Juusela A, Nazir M, Gimovsky M. Two cases of coronavirus 2019-related cardiomyopathy in pregnancy. Am J Obstet Gynecol MFM. 2020/04/03. 2020;2(2):100113. Available from:
  10. Edy Parwanto ML, Digambiro RA, Nusantara DU, Rarasati T. Coronavirus disease 2019 (COVID-19): A case report in a patient with diabetic ketoacidosis and hypertension. Bali Med J. 2020;9(3):624. Available from:
  11. Di Toro F, Gjoka M, Di Lorenzo G, De Santo D, De Seta F, Maso G, et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect. 2020/11/02. 2021;27(1):36–46. Available from:
  12. Mongula JE, Frenken MWE, van Lijnschoten G, Arents NLA, de Wit-Zuurendonk LD, Schimmel-de Kok APA, et al. COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy. Ultrasound Obstet Gynecol. 2020/10/19. 2020;56(5):773–6. Available from:
  13. Selzman CH, Tonna JE, Pierce J, Vargas C, Skidmore C, Lewis G, et al. A pilot trial of human amniotic fluid for the treatment of COVID-19. BMC Res Notes. 2021;14(1):32. Available from:
  14. Saroyo YB, Rumondang A, Febriana IS, Harzif AK, Irwinda R. Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report. Infect Dis Rep. 2021;13(2):437–43. Available from:
  15. Karimi L, Makvandi S, Vahedian-Azimi A, Sathyapalan T, Sahebkar A. Effect of COVID-19 on Mortality of Pregnant and Postpartum Women: A Systematic Review and Meta-Analysis. J Pregnancy. 2021;2021:8870129. Available from:

How to Cite

Parwanto, E., Digambiro, R. A., Astato, E., & Guyansyah, A. (2022). Fatality in a pregnant woman with COVID-19 after a cesarean section: A case report. Bali Medical Journal, 11(1), 451–454.




Search Panel